Manulife (Manufacturers Life Insurance)’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-15,501
Closed -$1.51K 4206
2015
Q1
$1.51K Buy
15,501
+1,596
+11% +$169K ﹤0.01% 1473
2014
Q4
$1.29K Sell
13,905
-375
-3% -$29.6K ﹤0.01% 1452
2014
Q3
$982 Buy
14,280
+422
+3% +$30.2K ﹤0.01% 1571
2014
Q2
$1.45M Sell
13,858
-1,002
-7% -$85.2K ﹤0.01% 1413
2014
Q1
$1.23K Buy
14,860
+144
+1% +$13.3K ﹤0.01% 1504
2013
Q4
$953 Buy
14,716
+1,092
+8% +$64.8K ﹤0.01% 1636
2013
Q3
$862 Sell
13,624
-278
-2% -$13.7K ﹤0.01% 1645
2013
Q2
$584K Buy
+13,902
New +$634K ﹤0.01% 1792

Manulife (Manufacturers Life Insurance)'s GEVA Position: Q2 2015 in Review

Manulife (Manufacturers Life Insurance) sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 15,501 shares — an estimated $1.51K sold.

Manulife (Manufacturers Life Insurance) first reported a position in GEVA in Q2 2013 and held it in 8 quarters. The position peaked at $1.45M in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Manulife (Manufacturers Life Insurance) reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 15,501 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $1.51K.
  • Manulife (Manufacturers Life Insurance) first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • Manulife (Manufacturers Life Insurance)'s SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.45M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2015, filed 14 Aug 2015.